Challenges of clinical trials in low- and middle-income countries
International Psychiatry · 2012-05 · 9 (2) · 30-31
DOI: 10.1192/s1749367600003039 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Psychiatry, online erschienen am 02.01.2018. Verfasst von Akwasi Osei. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Clinical trials have been conducted almost wholly in high-income countries until recently, yet their results may not always be valid or applicable in middle- and low-income countries. Clinical trials are now, though, increasingly being done in less wealthy countries. While this is welcome, there is a need to ensure the profit motive does not override the benefits. Partnership with local counterparts while adhering to international standards should help to maintain high-quality output from clinical trials.
Zitieren
APA
Osei, A. (2012). Challenges of clinical trials in low- and middle-income countries. International Psychiatry, 9(2), 30-31. https://doi.org/10.1192/s1749367600003039
Vancouver
Osei A. Challenges of clinical trials in low- and middle-income countries. International Psychiatry. 2012;9(2):30-31. doi:10.1192/s1749367600003039
BibTeX
@article{Osei2012,
author = {Osei, Akwasi},
title = {Challenges of clinical trials in low- and middle-income countries},
journal = {International Psychiatry},
year = {2012},
volume = {9},
number = {2},
pages = {30--31},
doi = {10.1192/s1749367600003039}
}
EUVIMED